Evaluation of Association Between Obstructive Sleep Apnea and the Severity of Coronary Artery Disease
NCT ID: NCT03066141
Last Updated: 2019-09-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
255 participants
OBSERVATIONAL
2017-02-14
2019-08-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Influence of Obstructive Sleep Apnea on the Severity of Coronary Artery Disease
NCT04741022
Prospective Observational Registry for Obstructive Sleep Apnea in Patients With Acute Myocardial Infarction
NCT03600246
OSA-ACS Project: Association of OSA and CPAP Therapy With Outcomes in ACS Patients
NCT03362385
Relationship Between Obstructive Sleep Apnea and Coronary Atherosclerosis
NCT01306526
Prevalence, Phenotypes, Predictors and Prognostic Implication of Obstructive Sleep Apnea in Pulmonary Hypertension
NCT05595200
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Consecutive patients of both sexes with coronary angiography from outpatient or inpatient departments of Fuwai Hospital were recruited into the study. The inclusion criteria were Chinese, aged 35 to 75 years with CAD verified by coronary angiography, and able to give informed written consent. The subjects were excluded if they had New York Heart Association Class III-IV degree with ejection fraction \< 45%, severe pulmonary disease, significant psychiatric disease, or history of pharyngeal surgery for OSA or current use of CPAP treatment for OSA. They were also excluded if they declined to participate or were unable to provide informed consent.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CAD with OSA
coronary artery disease with Obstructive sleep apnea
No interventions assigned to this group
CAD without OSA
coronary artery disease without Obstructive sleep apnea
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* CAD was verified by coronary angiography
Exclusion Criteria
* Severe pulmonary disease
* Significant psychiatric disease
* History of pharyngeal surgery for OSA or current use of CPAP treatment for OSA
* Subjects declined to participate or were unable to provide informed consent.
35 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese Pulmonary Vascular Disease Research Group
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zhihong Liu, M.D
Role: STUDY_CHAIR
Chinese Academy of Medical Sciences, Fuwai Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
center of pulmonary vascular disease, Fuwai hospital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ChinesePVDRG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.